Key Market Indicators
Lithuania's insulin import is expected to reach $26 million by 2026, up 1.9% annually since 2021. Since 1999, Lithuanian demand has grown 3.4% annually. Lithuania's insulin export is expected to reach $14.2 million by 2026, up 2.9% annually since 2021. Since 1999, Lithuanian supply has increased 7.1% annually. In 2021, Ukraine overtook Lithuania, becoming the 19th largest insulin exporter with $12 million, while France, Italy and China ranked second, third and fourth, respectively.
